The fund is the result of a collaboration between Cheshire & Warrington Local Enterprise Partnership
Catapult Ventures has appointed a new venture partner with its Alderley Park-based GM&C Life Sciences Fund.
Chris Spencer will assess investment opportunities and work with the fund's smaller investments to help companies grow, with a particular focus on digital health.
Spencer was until recently chief executive of EMIS Group. He has almost 40 years' experience of general management, leadership, law and software/digital development within the healthcare, legal and educational sectors, both as a founder of his own companies and a senior manager in established companies.
Spencer said: "I am delighted to be expanding my role with Catapult Ventures and the GM&C Life Sciences Fund helping to advance not only digital health generally but also with a particular link to the North of England."
Catapult chief executive Nick Wright added: "I am delighted to welcome Chris to Catapult as a venture partner specialising in digital health.
"Chris has been working with Catapult as our digital health advisor for several months and his insights were invaluable during our investment in Gendius in September this year. Digital convergence in healthcare is an area Catapult is particularly excited about and having someone of Chris' calibre in the team will help us make even better, more informed investment decisions."
The GM&C Life Sciences Fund is a seed and early-stage venture capital fund targeting life sciences businesses in the Greater Manchester and Cheshire and Warrington region. The fund is managed by Catapult Ventures.
The fund is the result of a collaboration between Cheshire & Warrington Local Enterprise Partnership, the Greater Manchester Combined Authority, Cheshire East Council and Manchester Science Partnerships.
